Erisyon
PrivateLast Round
Grant
Jan 7, 2025
Total Funding Raised
$3.08M
Company Overview
Erisyon operates in Healthcare & Life Sciences and is based in Austin, Texas. Its latest recorded funding round was a Grant round in January 2025.
Erisyon Inc. is a biotechnology company that is commercializing a single-molecule protein sequencing platform to detect, treat, and track disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Erisyon Comparables
Compare Erisyon with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genopore | 88% | |
| Encodia | 87% | |
| Primary Bioscience | 86% |
For institutional investors. Book with your work email.
Erisyon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 7, 2025 | ||||
| Grant | Sep 22, 2022 | ||||
| Seed | Nov 30, 2020 | ||||
| Grant | Jun 1, 2020 | ||||
| Grant | May 14, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Erisyon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Research Bridge Partners | Seed |
| Cancer Prevention and Research Institute of Texas | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors increased 148% MoM, reaching 1.4K.
- May 4, 2025
Monthly visitors grew 580% MoM, reaching 1.4K.
For institutional investors. Book with your work email.
Erisyon Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Erisyon's valuation, stock price, and market status.
Is Erisyon a public or private company?
Erisyon is a private company.
What is the current stock price of Erisyon?
Erisyon is a private company, so its shares have no public market price. Caplight tracks Erisyon's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Erisyon worth (valuation)?
Valuation information for Erisyon is not publicly available.
Can I buy Erisyon stock?
Erisyon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Erisyon's last funding round?
Erisyon's most recent funding round was Grant on January 7, 2025.
Who are the main investors in Erisyon?
Key investors in Erisyon include Research Bridge Partners.
Will Erisyon IPO soon?
No public IPO plans have been announced for Erisyon.
How can I track Erisyon secondary market activity?
Caplight tracks bids, offers, and trades in Erisyon's shares on secondary markets.